Latest News
Cydar Medical Deploys Cydar Maps Technology at a Major New York Academic Medical System to Advance Vascular Surgery Outcomes with AI-Driven Surgical Intelligence
Cydar Medical, the global leader in AI-driven surgical intelligence, today announced the deployment of Cydar Maps across the vascular surgery program at a major academic medical center in the New York metropolitan area. This technology marks a significant step forward...
News feed
Articles (25)
Medical Device Network Excellence Awards 2023: Cydar Medical
Category Award Winner for Innovation and Product Launches: Medical software company leverages its market-leading AI solution to unlock the full potential of minimally invasive surgical procedures Cydar Medical is a Cambridge, UK, based health-technology company whose...
First patient treated in strategic collaboration with Medtronic
FIRST PATIENT TREATED IN GLOBAL STRATEGIC COLLABORATION WITH MEDTRONIC 40-site pilot program across US, UK and Europe aims to introduce cutting edge AI solutions into the clinical environment to improve patient care and efficiency Cydar Maps used to successfully treat...
Frimley Health NHS Foundation Trust, UK randomizes first patient
We are delighted that Frimley Health NHS Foundation Trust has randomised its first patient in the ARIA Study with Mr David Gerrard as Principal Investigator!! Hear about the importance of the ARIA Study for the NHS from Mr David Gerrard below. The ARIA Study is a...
Sarasota Memorial adopts Cydar Maps into their practice
We are delighted to announce Sarasota Memorial Health Care System has successfully adopted Cydar Maps into their cutting-edge healthcare practice! We extend our thanks to Dr. Edwards and outstanding team for selecting Cydar Maps to elevate their surgical capabilities...
Brighton & Sussex University Hospital NHS Trust in ARIA Study
We are delighted that Brighton & Sussex University Hospitals NHS Trust has randomised its first patient in the ARIA Study with Professor Syed Waquar Yusufas as Principal Investigator!! The ARIA Study is a randomised controlled trial to assess the clinical,...
Ochsner Health adopts Cydar Maps into their practice
We are delighted to announce that Ochsner Health has treated its first patient using Cydar Maps!! Dr Brinster and his team successfully performed their first EVAR case with the assistance and power of cloud-based AI. Thank you to Dr Clayton Brinster, MD, FACS and the...
Kenneth Hitchner Appointed as Chairman of Cydar Medical
Appointment to support Company’s ambitious growth strategy to create value across its platform Follows a transformative 2022 having expanded the Cydar Maps product to provide a compelling solution for image guided minimally invasive endovascular procedures and signed...
Cydar Medical Raises $11.5M (£9.3M) In Series A Funding Round
Successful fundraising led by Pembroke VCT and Downing Healthcare Ventures Proceeds will enable the Company to rapidly scale-up the commercial roll-out of its 3D AI surgical maps product and continue to advance its plans to create value across its innovative...
Leeds Teaching Hospital NHS Trust randomizes into the ARIA Study
We are delighted that Leeds Teaching Hospitals NHS Trust has randomised its first patient in the ARIA Study with Mrs Rosie Darwood as Principal Investigator!! The ARIA Study is a randomised controlled trial to assess the #clinical, technical and cost-effectiveness of...
Cydar Medical Announces Appointment of Chief Commercial Officer
Cydar Medical, a global, cloud-based surgical software company, announces that Alastair Harvey has been appointed in the newly created position of Chief Commercial Officer Cydar Medical, a global, cloud-based surgical software company, announces that Alastair Harvey...